3660
X.-W. Pu et al. / Tetrahedron 66 (2010) 3655–3661
71.2, 68.4, 64.8, 61.7, 55.9, 44.7, 39.0, 20.9, 20.6, 20.4; HRMS (ESI)
4.3. Typical procedure for asymmetric conjugate addition
reaction of acetylacetone 4 to nitroolefins 5 catalyzed by
catalyst 1
calcd for C26H37N3O9S [Mþ1]þ, 568.2323, found 568.2320.
4.2.6. (4S,5S,6R)-2-(Acetoxymethyl)-6-(3-((R)-1-(dimethylamino)-3-
Catalyst 1a (10.4 mg, 0.02 mmol, 10 mol %) was added to a vial
containing acetylacetone 4 (40 mg, 0.4 mmol) and nitroolefins 5
(0.2 mmol) in dry THF (0.6 mL) at room temperature. The resulting
mixture was stirred at room temperature, and the reaction was
monitored by TLC. The reaction mixture was quenched with 1 M
aqueous HCl solution, extracted with EtOAc, and dried over Na2SO4.
The crude product was purified by flash silica gel chromatography
to give the desired adducts 6. The ee values were determined by
chiral HPLC analysis.
phenylpropan-2-yl)thioureido)tetrahydro-2H-pyran-3,4,5-triyl
20
triacetate (1c0). Yield 431 mg (76%); [
a
]
D
þ14.0 (c 1.0, CHCl3); 1H
NMR (300 MHz, CDCl3): d 7.29–7.27 (m, 2H), 7.22–7.19 (m, 3H), 7.07
(br s, 1H), 5.84 (m, 1H), 5.34 (t, J¼9.4 Hz, 1H), 5.07 (t, J¼9.7 Hz, 1H),
4.95 (m, 1H), 4.35 (dd, J¼4.1, 3.8 Hz, 1H), 4.08 (m, 1H), 3.87
(d, J¼9.9 Hz,1H), 2.99 (m, 2H), 2.47 (m, 2H), 2.17 (s, 6H), 2.04 (s, 6H),
2.02 (s, 6H); 13C NMR (75 MHz, CDCl3):
d 183.6, 170.5, 170.3, 169.8,
169.5, 137.2, 129.4, 128.5, 126.6, 82.8, 73.3, 71.1, 68.3, 61.8, 53.5, 45.1,
38.6, 20.9, 20.5, 20.4; HRMS (ESI) calcd for C26H37N3O9S [Mþ1]þ,
568.2323, found 568.2320.
4.3.1. (S)-3-(2-Nitro-1-phenylethyl)pentane-2,4-dione
NMR (300 MHz, CDCl3): 7.34–7.26 (m, 3H), 7.20–7.17 (m, 2H),
(6a)9g 1H
.
d
4.2.7. (4S,5S,6R)-2-(Acetoxymethyl)-6-(3-((S)-2-(dimethylamino)-1-
4.67–4.62 (m, 2H), 4.37 (d, J¼10.8 Hz, 1H), 4.28–4.24 (m, 1H), 2.30
phenylethyl)thioureido)tetrahydro-2H-pyran-3,4,5-triyl
triacetate
20
þ28.0 (c 1.0, CHCl3); 1H NMR
(s, 3H), 1.94 (s, 3H); HPLC (Chiralpak AS-H, i-propanol/hexane¼15/
(1d). Yield 448 mg (81%); [
(300 MHz, CDCl3):
a
]
D
85, flow rate 1.0 mL/min,
tR,minor¼24.3 min.
l¼210 nm): tR,major¼15.5 min,
d
7.39–7.31 (m, 3H), 7.25–7.23 (m, 2H), 6.65 (br s,
1H), 5.76 (m, 1H), 5.33 (t, J¼9.5 Hz, 1H), 5.09 (t, J¼9.9 Hz, 1H), 4.95
(t, J¼9.4 Hz, 1H), 4.30 (dd, J¼4.2, 4.1 Hz, 1H), 4.12 (m, 1H), 3.87
(m, 1H), 2.90 (m, 1H), 2.53 (dd, J¼1.7, 1.7 Hz, 1H), 2.35 (s, 6H), 2.06
4.3.2. (S)-3-(1-(4-Chlorophenyl)-2-nitroethyl)pentane-2,4-dione
(6b)9g 1H NMR (300 MHz, CDCl3):
(s, 3H), 2.04 (s, 3H), 2.01 (s, 6H); 13C NMR (75 MHz, CDCl3):
d 184.4,
.
d
7.31 (d, J¼6.5 Hz, 2H), 7.14 (d,
J¼6.5 Hz, 2H), 4.62 (d, J¼6.6 Hz, 2H), 4.33 (d, J¼10.7 Hz, 1H), 4.27–
170.5, 170.3, 169.8, 169.6, 139.4, 129.2, 128.5, 126.5, 83.6, 73.4, 73.2,
71.1, 68.4, 66.6, 61.8, 58.8, 45.1, 20.6, 20.5; HRMS (ESI) calcd for
C25H35N3O9S [Mþ1]þ, 554.2167, found 554.2178.
4.25 (m, 1H), 2.30 (s, 3H), 1.98 (s, 3H); HPLC (Chiralpak AS-H,
i-propanol/hexane¼15/85, flow rate 1.0 mL/min, ¼210 nm): tR,ma-
l
¼15.8 min, tR,minor¼33.7 min.
jor
4.2.8. (4S,5S,6R)-2-(Acetoxymethyl)-6-(3-((R)-2-(dimethylamino)-1-
4.3.3. (S)-3-(1-(4-Bromophenyl)-2-nitroethyl)pentane-2,4-dione
(6c)9g 1H NMR (300 MHz, CDCl3):
phenylethyl)thioureido)tetrahydro-2H-pyran-3,4,5-triyl
triacetate
.
d
7.47 (d, J¼6.6 Hz, 2H), 7.07 (d,
20
(1d0). Yield 448 mg (81%); [
(300 MHz, CDCl3):
a
]
D
þ3.0 (c 1.0, CHCl3); 1H NMR
J¼6.7 Hz, 2H), 4.62–4.60 (m, 2H), 4.34 (d, J¼10.7 Hz, 1H), 4.26–4.23
d
7.28–7.19 (m, 5H), 5.74 (m, 1H), 5.26
(m, 1H), 2.30 (s, 3H), 1.98 (s, 3H); HPLC (Chiralpak AS-H, i-propanol/
(t, J¼9.5 Hz, 1H), 4.97 (t, J¼9.6 Hz, 1H), 4.86 (m, 1H), 4.20 (dd, J¼4.2,
4.1 Hz, 1H), 4.02 (m, 1H), 3.76 (m, 1H), 2.71 (m, 1H), 2.34 (dd, J¼3.8,
3.7 Hz, 1H), 2.19 (s, 6H), 1.97 (s, 3H), 1.94 (s, 3H), 1.92 (s, 6H); 13C
hexane¼15/85, flow rate 1.0 mL/min,
tR,minor¼32.0 min.
l¼210 nm): tR,major¼16.9 min,
NMR (75 MHz, CDCl3):
d 183.7, 170.8, 170.6, 169.8, 169.6, 139.9,
4.3.4. (S)-3-(2-Nitro-1-(2-(trifluoromethyl)phenyl)ethyl)pentane-
2,4-dione (6d)9g 1H NMR (300 MHz, CDCl3):
128.8, 127.8, 126.5, 82.9, 73.3, 73.0, 71.1, 68.4, 68.2, 67.8, 65.1, 61.8,
56.6, 45.0, 20.6, 20.5; HRMS (ESI) calcd for C25H35N3O9S [Mþ1]þ,
554.2167, found 554.2178.
.
d
7.69 (d, J¼7.6 Hz,1H),
7.46 (t, J¼7.2 Hz, 1H), 7.37 (t, J¼7.6 Hz, 1H), 7.20 (d, J¼7.5 Hz, 1H),
4.81–4.75 (m,1H), 4.62–4.55 (m, 3H), 2.25 (s, 3H),1.94 (s, 3H); HPLC
(Chiralcel OD-H, i-propanol/hexane¼10/90, flow rate 1.0 mL/min,
4.2.9. (3R,5S,6R)-2-(Acetoxymethyl)-6-(3-((S)-1-(dimethylamino)-3-
(1H-indol-3-yl)propan-2-yl)thioureido)tetrahydro-2H-pyran-3,4,5-
l¼210 nm): tR,major¼15.9 min, tR,minor¼17.8 min.
20
4.3.5. (S)-3-(2-Nitro-1-p-tolylethyl)pentane-2,4-dione
NMR (300 MHz, CDCl3):
(6e)9g 1H
.
triyl triacetate (1e). Yield 467 mg (77%); [
a
]
ꢁ10.0 (c 1.0, CHCl3);
D
1H NMR (300 MHz, CDCl3):
d
8.83 (br s, 1H), 7.47 (br s, 1H), 7.32 (d,
d
7.12 (d, J¼8.0 Hz, 2H), 7.06 (d, J¼8.2 Hz,
J¼7.9 Hz, 1H), 7.15–7.03 (m, 2H), 6.97 (br s, 1H), 6.42 (br s, 1H), 5.64
(d, J¼8.6 Hz, 1H), 5.24 (t, J¼9.5 Hz, 1H), 5.01 (t, J¼9.8 Hz, 1H), 4.87
(m, 1H), 4.17 (dd, J¼3.7, 3.4 Hz, 1H), 4.05 (d, J¼11.5 Hz, 1H), 3.77 (m,
2H), 2.81 (br s, 2H), 2.48 (m, 2H), 2.19 (s, 6H), 1.96 (s, 12H); 13C NMR
2H), 4.62–4.59 (m, 2H), 4.5 (d, J¼10.9 Hz, 1H), 4.22 (m, 1H), 2.30
(s, 3H), 2.29 (s, 3H), 1.94 (s, 3H); HPLC (Chiralpak AS-H, i-propanol/
hexane¼15/85, flow rate 1.0 mL/min,
tR,minor¼19.4 min.
l¼210 nm): tR,major¼12.5 min,
(75 MHz, CDCl3):
d 184.5, 170.6, 169.9, 169.8, 136.6, 126.9, 123.3,
122.2, 119.5, 118.2, 111.6, 110.0, 83.8, 73.2, 71.2, 68.4, 68.2, 67.9, 65.9,
61.8, 54.6, 44.9, 29.6, 20.6; HRMS (ESI) calcd for C28H38N4O9S
[Mþ1]þ, 607.2423, found 607.2438.
4.3.6. (S)-3-(1-(4-Methoxyphenyl)-2-nitroethyl)pentane-2,4-dione
(6f)9g 1H NMR (300 MHz, CDCl3):
.
d
7.10 (d, J¼6.8 Hz, 2H), 6.84
(d, J¼6.8 Hz, 2H), 4.60 (d, J¼6.9 Hz, 2H), 4.34 (d, J¼10.9 Hz, 1H), 4.12
(m, 1H), 3.78 (s, 3H), 2.29 (s, 3H), 1.94 (s, 3H); HPLC (Chiralpak AD-
4.2.10. (3R,5S,6R)-2-(Acetoxymethyl)-6-(3-((R)-1-(dimethylamino)-
H, i-propanol/hexane¼5/95, flow rate 0.8 mL/min,
l
¼210 nm):
3-(1H-indol-3-yl)propan-2-yl)thioureido)tetrahydro-2H-pyran-
tR,major¼40.6 min, tR,minor¼66.5 min.
20
3,4,5-triyl triacetate (1e0). Yield 484 mg (80%); [
a
]
þ30.0 (c 1.0,
D
CHCl3); 1H NMR (300 MHz, CDCl3):
d
8.85 (br s, 1H), 7.58 (br s,
4.3.7. (S)-3-(1-(2-(Benzyloxy)phenyl)-2-nitroethyl)pentane-2,4-di-
one (6g)9g 1H NMR (300 MHz, CDCl3):
7.51–7.40 (m, 5H), 7.26 (m,
1H), 7.36 (d, J¼7.7 Hz, 1H), 7.17–7.05 (m, 2H), 6.99 (br s, 1H), 6.52
(br s, 1H), 5.77 (d, J¼5.8 Hz, 1H), 5.29 (t, J¼9.2 Hz, 1H), 5.03
(t, J¼9.7 Hz, 1H), 4.76 (m, 1H), 4.25 (d, J¼7.3 Hz, 1H), 4.08 (m, 1H),
3.79 (m, 2H), 2.96 (br s, 2H), 2.49 (br s, 2H), 2.09 (s, 6H), 2.03
.
d
1H), 7.10 (m, 1H), 6.98–6.91 (m, 2H), 5.13 (s, 2H), 4.80–4.77 (m, 1H),
4.57–4.53 (m, 3H), 2.18 (s, 3H), 1.91 (s, 3H); HPLC (Chiralpak AS-H,
i-propanol/hexane¼10/90, flow rate 0.8 mL/min,
l¼210 nm):
(s, 6H), 2.02 (s, 6H); 13C NMR (75 MHz, CDCl3):
d 184.2, 171.2,
tR,major¼20.2 min, tR,minor¼22.1 min.
170.7, 169.9, 169.7, 136.4, 127.4, 123.3, 122.2, 119.6, 118.6, 111.5,
110.3, 83.2, 73.3, 71.2, 68.4, 68.2, 65.0, 61.9, 53.5, 45.1, 29.6, 20.7,
20.5; HRMS (ESI) calcd for C28H38N4O9S [Mþ1]þ, 607.2423, found
607.2438.
4.3.8. (R)-3-(4-Methyl-1-nitropentan-2-yl)pentane-2,4-dione
(6h)7b 1H NMR (300 MHz, CDCl3):
4.51 (m, 2H), 3.99 (d, J¼8.4 Hz,
1H), 2.90 (m,1H), 2.28 (s, 3H), 2.25 (s, 3H),1.69 (m,1H),1.35 (m,1H),
.
d